Effects of treatment for diabetes mellitus on circulating vascular progenitor cells

Journal of Pharmacological Sciences

Volumn 102, Issue 1, 2006, Pages 96-102

  Kusuyama, Takanori ^a   Omura, Takashi ^b   Nishiya, Daisuke ^a   Enomoto, Soichiro ^a   Matsumoto, Ryo ^a   Takeuchi, Kazuhide ^a   Yoshikawa, Junichi ^c   Yoshiyama, Minoru ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY   (Japan)

^c Osaka Ekisaikai Hospital   (Japan)

Author keywords

Diabetes mellitus; Endothelial progenitor cell; Glycemic control; Smooth muscle progenitor cell

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN; INSULIN; PIOGLITAZONE; SULFONYLUREA;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LABELING; CIRCULATING ENDOTHELIAL PROGENITOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DIABETES CONTROL; DIABETES MELLITUS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; SMOOTH MUSCLE PROGENITOR CELL; STEM CELL; TREATMENT OUTCOME;

EID: 33748969496     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060256     Document Type: Article

References (16)

1. Former JA, Gotto AM. Dyslipidemia and Other Risk Factors for Coronary Disease. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease. 5th ed. A textbook of cardiovascular medicine. Philadelphia, Pennsylvania: W.B. Saunders Company; 1999. p. 1150.
2. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:E14-E22.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
4. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation. 2002;106:1199-1204.
5. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600.
6. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes. 2004;53:195-199.
7. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403-409.
8. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
9. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension. 2005;45:526-529.
10. Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation. 2005;111:926-931.
11. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776-2779.
12. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781-2786.
13. Patterson C. The Ponzo effect: endothelial progenitor cells appear on the horizon. Circulation. 2003;107:2995-2997.
14. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107:1164-1169.
15. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med. 2001;7:382-383.
16. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA. 2002;288:2579-2588.